BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/16/2022 10:48:15 AM | Browse: 439 | Download: 696
 |
Received |
|
2021-12-31 01:13 |
|
Peer-Review Started |
|
2021-12-31 01:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-24 02:10 |
|
Revised |
|
2022-02-14 00:50 |
|
Second Decision |
|
2022-04-12 01:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-21 18:13 |
|
Articles in Press |
|
2022-04-21 18:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-24 01:58 |
|
Publish the Manuscript Online |
|
2022-05-16 10:48 |
| ISSN |
1948-5190 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Andrew Canakis and Linda S Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Linda S Lee, MD, Associate Professor, Director, Director, Division of Gastroenterology Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, United States. llee@bwh.harvard.edu |
| Key Words |
Gastroenteropancreatic neuroendocrine neoplasms; Neuroendocrine tumors; Neuroendocrine carcinoma; Gastrointestinal; Pancreas; Small intestine |
| Core Tip |
Diagnostic technology for neuroendocrine tumors continues to advance. Radiomics promises to enhance morphologic imaging. Gallium-68 DOTA-peptide positron emission tomography/computed tomography has replaced Octreoscan as the preferred functional imaging modality. Newer radiolabeled peptides may further improve detection. A novel liquid biopsy biomarker (NETest) has proven more accurate than chromogranin A in monitoring treatment response and predicting disease activity. Therapy has also progressed with treatment adapted based on the predicted behavior of the tumor. Advanced endoscopic resection techniques have revolutionized treatment. Preliminary evidence suggests endoscopic ultrasound guided radiofrequency ablation may prove useful in treating pancreatic lesions. Multimodality therapy continues to evolve for metastatic pancreatic tumors. |
| Publish Date |
2022-05-16 10:48 |
| Citation |
Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 |
| URL |
https://www.wjgnet.com/1948-5190/full/v14/i5/267.htm |
| DOI |
https://dx.doi.org/10.4253/wjge.v14.i5.267 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
